BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36621630)

  • 1. Proteomic profile of nuclei containing p62-positive inclusions in a patient with neuronal intranuclear inclusion disease.
    Kurihara M; Mano T; Eto F; Yao I; Sato K; Ohtomo G; Bannai T; Shibata S; Ishiura H; Ikemura M; Matsubara T; Morishima M; Saito Y; Murayama S; Toda T; Setou M; Iwata A
    Neurobiol Dis; 2023 Feb; 177():105989. PubMed ID: 36621630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranuclear inclusions in skin biopsies are not limited to neuronal intranuclear inclusion disease but can also be seen in oculopharyngodistal myopathy.
    Ogasawara M; Eura N; Nagaoka U; Sato T; Arahata H; Hayashi T; Okamoto T; Takahashi Y; Mori-Yoshimura M; Oya Y; Nakamura A; Shimazaki R; Sano T; Kumutpongpanich T; Minami N; Hayashi S; Noguchi S; Iida A; Takao M; Nishino I
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12787. PubMed ID: 34927285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and neuropathological picture of adult neuronal intranuclear inclusion disease with no radiological abnormality.
    Miki Y; Kamata K; Goto S; Sakuraba H; Mori F; Yamagata K; Kijima H; Fukuda S; Wakabayashi K
    Neuropathology; 2022 Jun; 42(3):204-211. PubMed ID: 35274390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-read sequencing identified repeat expansions in the 5'UTR of the
    Deng J; Gu M; Miao Y; Yao S; Zhu M; Fang P; Yu X; Li P; Su Y; Huang J; Zhang J; Yu J; Li F; Bai J; Sun W; Huang Y; Yuan Y; Hong D; Wang Z
    J Med Genet; 2019 Nov; 56(11):758-764. PubMed ID: 31413119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome.
    Ma L; Herren AW; Espinal G; Randol J; McLaughlin B; Martinez-Cerdeño V; Pessah IN; Hagerman RJ; Hagerman PJ
    Acta Neuropathol Commun; 2019 Sep; 7(1):143. PubMed ID: 31481131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case.
    Sugiyama A; Takeda T; Koide M; Yokota H; Mukai H; Kitayama Y; Shibuya K; Araki N; Ishikawa A; Isose S; Ito K; Honda K; Yamanaka Y; Sano T; Saito Y; Arai K; Kuwabara S
    BMC Neurol; 2021 Jul; 21(1):273. PubMed ID: 34243731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH2NLC GGC repeat expansion causes retinal pathology with intranuclear inclusions throughout the retina and causes visual impairment.
    Sone J; Ueno S; Akagi A; Miyahara H; Tamai C; Riku Y; Yabata H; Koizumi R; Hattori T; Hirose H; Koyanagi Y; Kobayashi R; Okada H; Kishimoto Y; Hashizume Y; Sobue G; Yoshida M; Iwasaki Y
    Acta Neuropathol Commun; 2023 May; 11(1):71. PubMed ID: 37131242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal intranuclear inclusion disease in patients with adult-onset non-vascular leukoencephalopathy.
    Liu YH; Chou YT; Chang FP; Lee WJ; Guo YC; Chou CT; Huang HC; Mizuguchi T; Chou CC; Yu HY; Yu KW; Wu HM; Tsai PC; Matsumoto N; Lee YC; Liao YC
    Brain; 2022 Sep; 145(9):3010-3021. PubMed ID: 35411397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic changes in neuronal intranuclear inclusion disease are linked to aberrant FUS interaction under hyperosmotic stress.
    Wang H; Zheng Y; Yu J; Meng L; Zhang W; Hong D; Wang Z; Yuan Y; Deng J
    Neurobiol Dis; 2024 Jan; 190():106391. PubMed ID: 38145851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive study of clinicopathological and genetic features of neuronal intranuclear inclusion disease.
    Liu M; Gao Y; Yuan Y; Liu X; Wang Y; Li L; Zhang X; Jiang C; Wang Q; Wang Y; Shi C; Xu Y; Yang J
    Neurol Sci; 2023 Oct; 44(10):3545-3556. PubMed ID: 37184590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin biopsy and neuronal intranuclear inclusion disease.
    Ren X; Tan D; Deng J; Wang Z; Hong D
    J Dermatol; 2023 Nov; 50(11):1367-1372. PubMed ID: 37718652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders.
    Tian Y; Wang JL; Huang W; Zeng S; Jiao B; Liu Z; Chen Z; Li Y; Wang Y; Min HX; Wang XJ; You Y; Zhang RX; Chen XY; Yi F; Zhou YF; Long HY; Zhou CJ; Hou X; Wang JP; Xie B; Liang F; Yang ZY; Sun QY; Allen EG; Shafik AM; Kong HE; Guo JF; Yan XX; Hu ZM; Xia K; Jiang H; Xu HW; Duan RH; Jin P; Tang BS; Shen L
    Am J Hum Genet; 2019 Jul; 105(1):166-176. PubMed ID: 31178126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases.
    Zhong S; Lian Y; Luo W; Luo R; Wu X; Ji J; Ji Y; Ding J; Wang X
    Acta Neuropathol; 2021 Dec; 142(6):1003-1023. PubMed ID: 34694469
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liao YC; Wei CY; Chang FP; Chou YT; Hsu SL; Chung CP; Mizuguchi T; Matsumoto N; Yet SF; Lee YC
    Stroke; 2023 May; 54(5):1236-1245. PubMed ID: 36942588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic origin of sporadic cases and RNA toxicity in neuronal intranuclear inclusion disease.
    Deng J; Zhou B; Yu J; Han X; Fu J; Li X; Xie X; Zhu M; Zheng Y; Guo X; Li P; Wang Q; Liu J; Zhang W; Yuan Y; Yao S; Wang Z; Hong D
    J Med Genet; 2022 May; 59(5):462-469. PubMed ID: 33766934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances in neuronal intranuclear inclusion disease.
    Bao L; Zuo D; Li Q; Chen H; Cui G
    Neurol Sci; 2023 Jun; 44(6):1881-1889. PubMed ID: 36795299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First detailed case report of a pediatric patient with neuronal intranuclear inclusion disease diagnosed by NOTCH2NLC genetic testing.
    Miyamoto Y; Okazaki T; Watanabe K; Togawa M; Adachi T; Kato A; Ochiai R; Tamai C; Sone J; Maegaki Y
    Brain Dev; 2023 Jan; 45(1):70-76. PubMed ID: 36150977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal intranuclear inclusion disease is genetically heterogeneous.
    Chen Z; Yan Yau W; Jaunmuktane Z; Tucci A; Sivakumar P; Gagliano Taliun SA; Turner C; Efthymiou S; Ibáñez K; Sullivan R; Bibi F; Athanasiou-Fragkouli A; Bourinaris T; Zhang D; Revesz T; Lashley T; DeTure M; Dickson DW; Josephs KA; Gelpi E; Kovacs GG; Halliday G; Rowe DB; Blair I; Tienari PJ; Suomalainen A; Fox NC; Wood NW; Lees AJ; Haltia MJ; ; Hardy J; Ryten M; Vandrovcova J; Houlden H
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1716-1725. PubMed ID: 32777174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of expanded GGC repeats within
    Liu Q; Zhang K; Kang Y; Li Y; Deng P; Li Y; Tian Y; Sun Q; Tang Y; Xu K; Zhou Y; Wang JL; Guo J; Li JD; Xia K; Meng Q; Allen EG; Wen Z; Li Z; Jiang H; Shen L; Duan R; Yao B; Tang B; Jin P; Pan Y
    Sci Adv; 2022 Nov; 8(47):eadd6391. PubMed ID: 36417528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predominance of "astrocytic" intranuclear inclusions in neuronal intranuclear inclusion disease manifesting encephalopathy-like symptoms: A case series with brain biopsy.
    Ishizawa K; Komori T; Homma T; Sone J; Nakata Y; Nakazato Y; Takahashi K; Yamamoto T; Sasaki A
    Neuropathology; 2024 Mar; ():. PubMed ID: 38477063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.